SMF Schweizerisches Medizin-Forum 1424-4020 1424-3784 EMH Schweizerischer Ärzteverlag AG Farnsburgerstrasse 8 CH-4132 Muttenz 08607 10.4414/smf.2020.08607 Übersichtsartikel Allergologie / Immunologie Klinische Pharmakologie und Toxikologie Labormedizin Neurologie Ophthalmologie Maladies neuro-inflammatoires Pantazou Vasiliki Vasiliki.pantazou@chuv.ch SWITZERLAND Beuchat Isabelle Unité de Neuro-Immunologie, Service de Neurologie, Département des Neurosciences Cliniques, CHUV Du Pasquier Renaud Unité de Neuro-Immunologie, Service de Neurologie, Département des Neurosciences Cliniques, CHUV 22 09 2020 20 3940 516 522 Copyright: EMH Schweizerischer Ärzteverlag AG 2020 EMH Schweizerischer Ärzteverlag AG "Swiss Medical Forum" is an open access publication of EMH published in accordance with the terms of the Creative Commons licence attribution - NonCommercial - NoDerivatives 4.0 International. You are free to share, copy and redistribute the material in any medium or format under the following terms: Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. NonCommercial — You may not use the material for commercial purposes. NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material. "Non-commercial" means not primarily intended for or directed towards commercial advantage or monetary compensation. The incorporation of publications in commercial products, the use of publications to advertise for commercial products or services and any other usage that directly or indirectly pursues commercial interests is subject to the express previous consent of the publishing house as part of a written agreement. Please send us your request in writing. Exact indication of the publication from which you would like to reproduce material and detailed information about its intended use help to facilitate and expedite request processing. <p>R&eacute;sum&eacute; Quintessence: Les nouvelles possibilit&eacute;s th&eacute;rapeutiques ont chang&eacute; l&rsquo;&eacute;volution et la prise en charge des patients souffrant de maladies neuro-inflammatoires, permettant dans de nombreux cas de ralentir la progression de la maladie. Une collaboration &eacute;troite entre neurologue et m&eacute;decin de famille est donc plus que jamais essentiel afin d&rsquo;assurer un diagnostic pr&eacute;coce, une introduction rapide et s&eacute;curitaire de traitements immunomodulateurs et un suivi r&eacute;gulier de leur toxicit&eacute; potentielle.</p>